Japan Veterinary Advanced Medical Center <6039> announced its consolidated financial results for the second quarter of the fiscal year ending March 2025 (April-September 24). Revenue increased by 29.6% to 2.569 billion yen compared to the same period last year, operating profit increased by 119.6% to 0.35 billion yen, ordinary profit increased by 131.3% to 0.351 billion yen, and net income attributable to parent company shareholders increased by 148.4% to 0.242 billion yen.
At existing hospitals, the recruitment of veterinarians has been progressing smoothly, leading to an improvement in the capacity of medical care, resulting in a significant increase in the number of medical consultations. Osaka Hospital, which started medical services in June 2023, achieved profitability in a single month in May 2024, twelve months after opening, and has been progressing smoothly since then. As a result, in secondary medical services, the number of initial consultations (new cases accepted) increased by 29.2% to 4,981 cases compared to the same period last year, the total number of medical consultations (including initial and follow-up visits) increased by 26.9% to 17,089 cases, and the number of surgeries increased by 29.8% to 1,502 cases compared to the same period last year. The number of affiliated hospitals increased by 191 from the previous year to a total of 4,551. Although imaging diagnosis services continued to strengthen their sales activities with primary medical facilities, some facilities underwent renovation to replace MRIs with the latest models, leading to closure in July and August, resulting in a stable number of examinations compared to the same period last year. The rental and sales of health management equipment increased compared to the previous year due to continued efforts to strengthen relationships with agents.
Regarding the full-year consolidated performance forecast for the fiscal year ending March 2025, the revenue is expected to increase by 12.9% to 4.82 billion yen compared to the previous period, operating profit is expected to increase by 25.8% to 0.625 billion yen, ordinary profit is expected to increase by 27.6% to 0.625 billion yen, and net income attributable to parent company shareholders is expected to increase by 30.5% to 0.44 billion yen based on the initial plan.